Faeth Therapeutics, Inc. SEC filings FTH
Faeth Therapeutics, Inc. has 452 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 3, 2026 | Oct 30, 2026 |
| S-8 | Employee stock plan registration | Nov 3, 2026 | — |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 10-Q | Quarterly report | Nov 3, 2026 | Sep 30, 2026 |
| 4 | Insider transaction | Oct 27, 2026 | Oct 23, 2026 |
| 3 | Initial insider ownership | Oct 27, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 17, 2026 | Sep 11, 2026 |
| 4 | Insider transaction | Sep 15, 2026 | Sep 11, 2026 |
| 3 | Initial insider ownership | Sep 15, 2026 | Sep 11, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 144 | Notice of proposed sale | Aug 11, 2026 | — |
| 10-Q | Quarterly report | Aug 4, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 3 | Initial insider ownership | Jul 28, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 23, 2026 | Jul 21, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jul 21, 2026 |
| 4 | Insider transaction | Jul 23, 2026 | Jul 21, 2026 |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 26, 2026 | Jun 24, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 4 | Insider transaction | Jun 24, 2026 | Jun 22, 2026 |
| 3 | Initial insider ownership | Jun 23, 2026 | Jun 13, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 23, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 23, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jun 18, 2026 | Jun 15, 2026 |
| S-3ASR | Automatic shelf registration | Jun 18, 2026 | — |
| 4 | Insider transaction | Jun 16, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 15, 2026 |
| 3 | Initial insider ownership | Jun 16, 2026 | Jun 12, 2026 |
| 4 | Insider transaction | Jun 16, 2026 | Jun 12, 2026 |
| 3 | Initial insider ownership | Jun 16, 2026 | Jun 12, 2026 |
| 4/A | Filing | Jun 16, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Agreement ended, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jun 15, 2026 | Jun 10, 2026 |
| EFFECT | Filing | Jun 12, 2026 | — |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| S-3/A | Filing | Jun 10, 2026 | — |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 10, 2026 | Jun 10, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 3, 2026 | — |
| 10-K/A | Amended annual report | Jun 2, 2026 | Dec 31, 2025 |
| S-3/A | Filing | Jun 2, 2026 | — |
| 4 | Insider transaction | Jun 1, 2026 | Jun 1, 2026 |
| 4 | Insider transaction | Jun 1, 2026 | Jun 1, 2026 |
| DEFA14A | Additional proxy material | May 22, 2026 | — |
| 8-K |
Current report
Other events
|
May 22, 2026 | May 22, 2026 |
| DEFA14A | Additional proxy material | May 21, 2026 | — |
| 8-K |
Current report
Other events
|
May 21, 2026 | May 21, 2026 |
| 4 | Insider transaction | May 15, 2026 | Apr 2, 2026 |
| 4 | Insider transaction | May 15, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | May 15, 2026 | Mar 26, 2026 |
| 3 | Initial insider ownership | May 15, 2026 | Mar 26, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2026 | — |
| S-8 | Employee stock plan registration | May 15, 2026 | — |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| 144 | Notice of proposed sale | Apr 29, 2026 | — |
| S-3 | Shelf registration | Apr 28, 2026 | — |
| ARS | Annual report to shareholders | Apr 27, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 27, 2026 | — |
| DEF 14A | Proxy statement | Apr 27, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2026 | Apr 10, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 16, 2026 | Jun 10, 2026 |
| 8-K/A | Amended current report | Apr 15, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Apr 14, 2026 | Apr 10, 2026 |
| 4 | Insider transaction | Apr 14, 2026 | Apr 10, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2026 | Mar 30, 2026 |
| D | Filing | Mar 4, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 25, 2026 | — |
| 144 | Notice of proposed sale | Feb 24, 2026 | — |
| 4 | Insider transaction | Feb 19, 2026 | Feb 17, 2026 |
| 3 | Initial insider ownership | Feb 19, 2026 | Feb 17, 2026 |
| 144 | Notice of proposed sale | Feb 18, 2026 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Feb 18, 2026 | Feb 17, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 13, 2026 |
| 3 | Initial insider ownership | Feb 17, 2026 | Feb 13, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2026 | Feb 13, 2026 |
| 144 | Notice of proposed sale | Jan 27, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2025 | Dec 22, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 9, 2025 |
| 144 | Notice of proposed sale | Dec 9, 2025 | — |
| 4 | Insider transaction | Dec 8, 2025 | Dec 4, 2025 |
| 4 | Insider transaction | Dec 8, 2025 | Dec 4, 2025 |
| 144 | Notice of proposed sale | Dec 4, 2025 | — |
| 144 | Notice of proposed sale | Dec 4, 2025 | — |
| 3 | Initial insider ownership | Nov 24, 2025 | Nov 14, 2025 |
| 10-Q | Quarterly report | Nov 14, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 17, 2025 | Oct 17, 2025 |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 9, 2025 | Jul 2, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 13, 2025 | Jun 12, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2025 | May 21, 2025 |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| ARS | Annual report to shareholders | Apr 11, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 11, 2025 | — |
| DEF 14A | Proxy statement | Apr 11, 2025 | May 21, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 1, 2025 | May 21, 2025 |
| S-8 | Employee stock plan registration | Mar 28, 2025 | — |
| 10-K | Annual report | Mar 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2025 | Mar 27, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 14, 2025 | Feb 14, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 7, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Dec 23, 2024 | Dec 20, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 30, 2024 | Oct 25, 2024 |
| 3 | Initial insider ownership | Sep 26, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2024 | Sep 17, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 12, 2024 | Jul 10, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 27, 2024 | Jun 26, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 4 | Insider transaction | Jun 13, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 23, 2024 | May 23, 2024 |
| 3 | Initial insider ownership | May 16, 2024 | May 10, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 29, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 29, 2024 | — |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2024 | Mar 27, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Mar 7, 2024 | — |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Mar 5, 2024 | Mar 5, 2024 |
| S-8 | Employee stock plan registration | Feb 29, 2024 | — |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 15, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 15, 2024 |
| 4 | Insider transaction | Feb 16, 2024 | Feb 15, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Feb 13, 2024 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 8, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2023 | Nov 6, 2023 |
| SC 13D | Ownership over 5% (active) | Nov 3, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2023 | Nov 3, 2023 |
| 4 | Insider transaction | Nov 2, 2023 | Nov 1, 2023 |
| 3 | Initial insider ownership | Nov 2, 2023 | Nov 1, 2023 |
| 8-K |
Current report
Listing notice
|
Oct 20, 2023 | Oct 17, 2023 |
| 4 | Insider transaction | Sep 13, 2023 | Sep 11, 2023 |
| 4 | Insider transaction | Sep 11, 2023 | Feb 15, 2023 |
| 4 | Insider transaction | Sep 11, 2023 | Feb 15, 2023 |
| 4 | Insider transaction | Sep 11, 2023 | Feb 15, 2023 |
| 4 | Insider transaction | Sep 11, 2023 | Feb 15, 2023 |
| 424B5 | Prospectus supplement | Aug 17, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Aug 4, 2023 | — |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 4 | Insider transaction | Aug 2, 2023 | Jul 31, 2023 |
| 4 | Insider transaction | Aug 2, 2023 | Jul 31, 2023 |
| 4 | Insider transaction | Jul 12, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jul 12, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jul 12, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jul 12, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jul 12, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jul 12, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jul 12, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jul 12, 2023 | Jul 10, 2023 |
| 4 | Insider transaction | Jul 12, 2023 | Jul 10, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jul 10, 2023 | Jul 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 27, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Jun 23, 2023 | Jun 23, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1829802
- Former names
- Sensei Biotherapeutics, Inc. (until Jun 16, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.